desoximetasone topical spray / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
desoximetasone topical spray / Generic mfg.
NCT02983981: Topical Psoriasis Study for Patients Receiving Biologic Therapy

Completed
4
20
NA
Topicort Topical Spray
Psoriasis Treatment Center of Central New Jersey, Taro Pharmaceuticals USA
Psoriasis
09/16
10/16
NCT02985736: Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray

Completed
4
20
US
Topicort Topical Spray
Psoriasis Treatment Center of Central New Jersey, Taro Pharmaceuticals USA
Psoriasis
01/17
01/17
NCT03050294: Evaluating Treatment Resistant Dermatitis TaroIIR

Completed
4
24
US
Phone calls, Desoximetasone 0.25% spray
Wake Forest University Health Sciences
Atopic Dermatitis, Psoriasis
06/17
06/17
NCT02340169: Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

Completed
4
129
US
Topicort® (desoximetasone) Topical Spray, 0.25%, desoximetasone
Taro Pharmaceuticals USA
Plaque Psoriasis
11/19
11/21

Download Options